Chitalia, Miliotis et al. evaluate radiomic predictors of outcome in patients with breast cancer treated with neoadjuvant chemotherapy. The authors identify radiomic phenotypes related to changes in tumor heterogeneity that improve progression-free survival prediction when added to clinicopathological and molecular factors.
- Rhea Chitalia
- Marios Miliotis
- Despina Kontos
